LIBERTYVILLE, Ill. — Valent BioSciences LLC and Seipasa have entered into a strategic partnership to introduce advanced biostimulant products to the U.S. agricultural market. As part of the agreement, Seipasa has appointed Valent BioSciences as its exclusive partner to commercialize its biostimulant technologies in the United States.
Seipasa, a leader in the development and production of biopesticides, biostimulants, and nutritional products for agriculture, has developed Sweetsei, an innovative biostimulant engineered with an optimized biochemical matrix. Sweetsei is designed to influence key plant pathways to enhance quality parameters in specialty crops, offering growers a new tool to improve harvest outcomes.
“We are excited to enter this strategic partnership with a globally recognized research and development company. Seipasa brings a scientific rigor to the biostimulant market that complements our own scientific standards,” said Salman Mir, President and CEO of Valent BioSciences. “And Sweetsei is a proven technology that will help farmers optimize their harvest.”
Pedro Peleato, CEO of Seipasa, emphasized the significance of the U.S. market in the company’s international growth plans. “The United States is a key market in our international expansion,” he said. “Sweetsei is a biostimulant with extensive international reach that is already present, with proven results, in markets across Latin America, Europe, and Africa. It is very exciting to be partnering with Valent BioSciences to bring our biostimulant solutions to farmers.”
Valent BioSciences established a dedicated business unit in 2022 to focus on biostimulant solutions for U.S. growers. Its acquisition of FBSciences in 2023 further expanded its offering with Transit-based biostimulant products, reinforcing the company’s commitment to advancing biological solutions in agriculture.
